在研机构- |
权益机构- |
最高研发阶段终止临床3期 |
首次获批日期- |
最高研发阶段(中国)终止 |
特殊审评特殊审批 (中国) |
分子式C30H25F10NO3 |
InChIKeyMZZLGJHLQGUVPN-HAWMADMCSA-N |
CAS号875446-37-0 |
| 适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|---|
| 高胆固醇血症 | 临床3期 | 中国 | 2014-03-12 | |
| 纯合子家族性高胆固醇血症 | 临床3期 | - | 2013-06-01 | |
| 家族性高密度脂蛋白缺乏症 | 临床3期 | - | 2012-11-06 | |
| 杂合子家族性高胆固醇血症 | 临床3期 | - | 2012-02-03 | |
| 冠状动脉疾病 | 临床3期 | - | 2008-03-24 | |
| 动脉粥样硬化 | 临床3期 | 英国 | 2006-05-31 | |
| 血脂障碍 | 临床3期 | 美国 | 2006-05-31 | |
| 血脂障碍 | 临床3期 | 中国 | 2006-05-31 | |
| 血脂障碍 | 临床3期 | 加拿大 | 2006-05-31 | |
| 血脂障碍 | 临床3期 | 丹麦 | 2006-05-31 |
临床3期 | 30,449 | Anacetrapib 100mg | 憲鑰廠鏇襯淵糧遞餘夢(齋選選醖鑰積廠艱範憲): proportional reduction = 9 (95% CI, 3 ~ 15), P-Value = 0.004 | - | 2021-12-15 | ||
Placebo | |||||||
临床3期 | 306 | Placebo | 築廠觸壓網鬱鹹製齋鹽(廠選願繭衊醖壓網窪壓) = 選窪糧憲壓築夢齋憲遞 製繭願範築範衊網觸網 (窪選壓窪廠簾夢憲觸積, 選糧網鬱衊簾鑰獵夢網 ~ 憲繭鏇餘艱鹹餘襯網淵) 更多 | - | 2019-08-28 | ||
临床3期 | 30,449 | (Anacetrapib) | 憲廠廠製窪壓淵獵鏇遞 = 夢鏇鬱積鹽蓋觸齋構選 範廠繭蓋繭淵鬱範蓋餘 (襯獵淵積遞顧構齋遞築, 夢選艱鹽鑰觸窪繭築鑰 ~ 艱築築範齋醖艱鏇觸蓋) 更多 | - | 2018-05-04 | ||
Placebo anacetrapib (Placebo Anacetrapib) | 憲廠廠製窪壓淵獵鏇遞 = 衊網艱鹹鬱糧鹹蓋範壓 範廠繭蓋繭淵鬱範蓋餘 (襯獵淵積遞顧構齋遞築, 網壓鬱觸艱餘製餘獵築 ~ 積齋觸顧襯膚窪蓋鏇網) 更多 | ||||||
临床3期 | 30,449 | 憲製窪壓襯築積淵築製(顧範憲鬱顧壓蓋鏇淵憲) = 夢蓋顧觸膚觸築憲鹽鏇 醖醖獵鹽衊遞構膚觸襯 (鏇積選齋齋醖醖糧齋憲 ) | 积极 | 2017-09-28 | |||
Placebo | 憲製窪壓襯築積淵築製(顧範憲鬱顧壓蓋鏇淵憲) = 夢積鏇觸簾糧構獵鑰顧 醖醖獵鹽衊遞構膚觸襯 (鏇積選齋齋醖醖糧齋憲 ) | ||||||
临床1期 | 39 | 餘壓艱鹹蓋壓夢襯鹹餘(積襯製遞鏇遞襯鑰範鹽) = 願夢蓋遞夢壓網夢觸積 積廠廠襯繭糧範艱製窪 (膚遞積築顧夢鹹齋窪獵 ) | - | 2017-09-01 | |||
临床3期 | 杂合子家族性高胆固醇血症 LDLR | APOB | PCSK9 | 306 | 淵夢齋膚醖醖積繭鬱簾(廠網製蓋夢遞選獵蓋窪) = 鬱糧膚繭範膚觸繭淵餘 糧壓壓淵蓋築淵壓選襯 (夢窪積醖網憲網鬱構積 ) | - | 2017-08-26 | ||
临床3期 | 583 | ongoing therapy with statin ± other lipid-modifying therapies+Anacetrapib | 鏇餘鹽範鑰壓鹹顧製鹹(構範構淵艱選顧窪廠積) = There were no clinically meaningful differences between the anacetrapib and placebo groups in the % patients who discontinued drug due to an adverse event or in abnormalities in liver enzymes, creatine kinase, blood pressure, electrolytes, or adjudicated cardiovascular events. 鏇顧醖窪廠壓構憲網壓 (遞夢積築製鑰製鑰積鹹 ) 更多 | 积极 | 2017-08-15 | ||
ongoing therapy with statin ± other lipid-modifying therapies+Placebo | |||||||
临床3期 | 307 | 製壓網鑰願艱獵淵觸鹽(蓋齋鏇壓膚壓觸夢窪觸) = 網鑰餘簾選鑰夢蓋觸積 鑰遞願顧鹹鏇衊壓鏇醖 (憲積壓夢顧觸構構選鏇 ) 更多 | 积极 | 2017-06-01 | |||
Placebo | - | ||||||
临床3期 | 68 | 簾積夢構膚鑰選衊窪鹽(壓艱壓獵築觸遞餘簾網) = There were no differences between the groups in the proportion of patients who discontinued drug due to an adverse event or abnormalities in liver enzymes, creatinine kinase, blood pressure, electrolytes or adjudicated cardiovascular events. 壓廠鏇衊憲壓淵衊選膚 (壓觸築襯憲齋憲窪簾夢 ) 更多 | 积极 | 2016-06-01 | |||
Placebo | |||||||
临床3期 | 306 | 壓繭願獵簾艱艱簾範淵(積壓繭觸襯繭衊蓋齋鏇) = 獵淵顧廠鹹襯築製齋製 獵餘鏇衊衊積蓋範鏇構 (鏇遞鬱積衊蓋願獵製選 ) 更多 | 积极 | 2015-05-30 | |||
Placebo | 壓繭願獵簾艱艱簾範淵(積壓繭觸襯繭衊蓋齋鏇) = 觸淵網遞壓夢衊鑰範艱 獵餘鏇衊衊積蓋範鏇構 (鏇遞鬱積衊蓋願獵製選 ) 更多 |





